Dr. Hunmin (Mike) Jung

 

Educational Background

  • B.S./M.S.  Korea University,  Chemistry/Bioorganic Chemistry
  • Ph.D.  Texas A&M University,  Biochemistry/Structural Biology
  • Postdoctoral Training:  UT Southwestern Medical Center, Biochemistry and University of Texas at Austin, College of Pharmacy,  Chemical Biology & Medicinal Chemistry

Research Focus

Structure-guided development of:

  • anticancer agents targeting DNA lesion repair/bypass and de novo nucleotide biosynthesis pathways
  • modulators that inhibit or enhance the incorporation of non-natural nucleotides into DNA or RNA
  • antidiabetic agents/biomarkers targeting glucose sensing transcription factors
  • antibacterial/antiviral agents targeting DNA repair/bypass and nucleotide metabolism